We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

56 hedge funds and large institutions have $297M invested in NeuroDerm Ltd. Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

73% more capital invested

Capital invested by funds: $171M → $297M (+$126M)

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

12% more funds holding

Funds holding: 50 → 56 (+6)

100% less call options, than puts

Call options by funds: $3K | Put options by funds: $2.77M

Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
1.4%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
15
Increased
26
Reduced
13
Closed
9
Calls
$3K
Puts
$2.77M
Net Calls
-$2.76M
Net Calls Change
-$2.25M

Top Buyers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
+$18.7M
2
RG
Redmile Group
California
+$14.1M
3
Franklin Resources
Franklin Resources
California
+$9.35M
4
Millennium Management
Millennium Management
New York
+$7.86M
5
ACA
Avoro Capital Advisors
New York
+$6.92M

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$5.27M
2
PA
Perceptive Advisors
New York
-$3.86M
3
NC
Nexthera Capital
New York
-$2.42M
4
SFM
Sphera Funds Management
Israel
-$1.45M
5
FHAM
Folger Hill Asset Management
New York
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
IBT
26
International Biotechnology Trust
United Kingdom
$1.44M +$1.22M +65,000 New
PA
27
Perceptive Advisors
New York
$1.28M -$3.86M -206,289 -78%
Deutsche Bank
28
Deutsche Bank
Germany
$1.27M +$934K +49,912 +678%
MCM
29
Moore Capital Management
New York
$1.11M +$935K +50,000 New
Victory Capital Management
30
Victory Capital Management
Texas
$1.03M +$398K +21,270 +84%
Northern Trust
31
Northern Trust
Illinois
$853K +$165K +8,833 +30%
DCM
32
DAFNA Capital Management
California
$842K +$440K +23,500 +163%
Swiss National Bank
33
Swiss National Bank
Switzerland
$722K +$181K +9,700 +43%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$603K -$233K -12,481 -31%
PPA
35
Parametric Portfolio Associates
Washington
$513K – – –
SM
36
Sabby Management
Florida
$511K +$431K +23,033 New
PCM
37
Pyrrho Capital Management
New York
$504K +$425K +22,700 New
AA
38
ALPS Advisors
Colorado
$461K -$128K -6,832 -25%
Goldman Sachs
39
Goldman Sachs
New York
$460K +$156K +8,342 +67%
TCIM
40
TIAA CREF Investment Management
New York
$433K +$202K +10,781 +124%
Morgan Stanley
41
Morgan Stanley
New York
$323K -$11.3K -605 -4%
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$222K +$187K +10,000 New
Geode Capital Management
43
Geode Capital Management
Massachusetts
$217K +$183K +9,805 New
Bank of America
44
Bank of America
North Carolina
$190K +$11.7K +625 +8%
Group One Trading
45
Group One Trading
Illinois
$127K +$22.1K +1,180 +26%
PCM
46
Prelude Capital Management
New York
$117K +$98.8K +5,283 New
Barclays
47
Barclays
United Kingdom
$101K +$21.4K +1,144 +34%
VanEck Associates
48
VanEck Associates
New York
$94K -$39.6K -2,118 -33%
UBS Group
49
UBS Group
Switzerland
$41K +$6.36K +340 +23%
PCM
50
Penserra Capital Management
California
$32K -$5.76K -308 -17%
1
2
3

NDRM Hedge Fund Activity: Q4 2016 in Review

56 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2016, worth a combined $297M — up 73% from $171M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NDRM positions and 9 closed out — a net gain of 6 holders — while 26 added to existing stakes and 13 trimmed.

The largest buyer was Scopia Capital Management, adding an estimated $18.7M. The largest seller was BlackRock Fund Advisors, cutting an estimated $5.27M.

  • 56 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2016, up from 50 in Q3 2016.
  • Funds reported $297M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2016, up 73% quarter-over-quarter.
  • 15 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2016 and 9 closed out, a net change of +6 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2016 was Scopia Capital Management, an estimated $18.7M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2016 was BlackRock Fund Advisors, an estimated $5.27M sold.

Based on aggregated 13F filings for Q4 2016.